Infervision
its InferRead AI performs sub-millimetre lung-nodule detection (below 5 mm nodules, ground-glass and vessel-convergence features) with individualized malignancy-probability scoring, deployed across Chinese hospitals along the patient pathway from screening to follow-up.
- Country
- China
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| AI pathology interpretation (computational pathology) | diagnostics-medtech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.